Role of platelet-activating factor in hepatectomy with Pringle's maneuver

Journal of Surgical Research

Volumn 96, Issue 2, 2001, Pages 233-238

  Gu, Mei ^a   Takada, Yasutsugu ^a   Fukunaga, Kiyoshi ^a   Ishiguro, Shingo ^a   Taniguchi, Hideki ^a   Seino, Kenichiro ^a   Yuzawa, Kenji ^a   Otsuka, Masaaki ^a   Todoroki, Takeshi ^a   Fukao, Katashi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Hepatectomy; Ischemia and reperfusion injury; Platelet activating factor; Pringle's maneuver

Indexed keywords

1 ETHYL 2 [N (2 METHOXYBENZOYL) N [2 METHOXY 3 [4 (OCTADECYLCARBAMOYLOXY)PIPERIDINOCARBONYLOXY]PROPOXYCARBONYL]AMINOMETHYL]PYRIDIN IUM CHLORIDE; 1 ETHYL 2 [N (2 METHOXYBENZOYL) N [2 METHOXY 3 [4 (OCTADECYLCARBAMOYLOXY)PIPERIDINOCARBONYLOXY]PROPOXYCARBONYL]AMINOMETHYL]PYRIDINIUM CHLORIDE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ENDOTHELIN 1; LACTATE DEHYDROGENASE; LIVER ENZYME; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL BLOOD; ARTICLE; BLOOD VESSEL OCCLUSION; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; ENERGY; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; LEUKOCYTE; LIVER FUNCTION; LIVER PROTECTION; LIVER RESECTION; NONHUMAN; PORTAL VEIN BLOOD; PORTAL VEIN BLOOD PRESSURE; PRINGLE MANEUVER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RABBIT; REPERFUSION; SURVIVAL RATE;

EID: 0035746821     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.6067     Document Type: Article

References (36)

1. Major liver resection: Perioperative course and management
2. Primary hepatic malignancy: Surgical management and determinants of survival
3. Notes on the arrest of hepatic hemorrhage due to trauma
4. Liver ischemia for hepatic resection: Where is the limit?
5. Portal triad clamping or hepatic vascular exclusion for major liver resection: A controlled study
6. Preservation and reperfusion injuries in liver allografts: An overview and synthesis of current studies
7. Protective effect of platelet-activating factor antagonist on hepatic energy metabolism following transient hepatic inflow occlusion in rabbits
8. Effects of platelet-activating factor antagonist E5880 on intrahepatic and systemic metabolic responses to transient hepatic inflow occlusion and reperfusion in the rabbits
9. 2 analogue
10. Platelet-activating factor antagonism enhances the liver's recovery from warm ischemia in situ
11. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbance
12. Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury
13. Partial hepatectomy in the dog: A revised technique based on anatomic considerations
14. Inhibitory effect of the novel platelet activating factor receptor antagonist, (E5880), in several experimentally induced shock models
15. Adenosine-5′-triphosphate: Determination with hexokinase and glucose-6-phosphate dehydrogenase
16. Adenosine-5′-diphosphate and adenosine-5′-monophosphate
17. The energy charge of the adenylate pool as a regulatory parameter: Interaction with feedback modifier
18. A sensitive sandwichenzyme immunoassay for human endothelin
19. Prediction and limitation of hepatic tumor resection without blood transfusion in cirrhotic patients
20. An analysis of 412 cases of hepatocellular carcinoma at a Western center
21. Hepatectomy for hepatocellular carcinoma: Toward zero hospital deaths
22. Physiologic considerations in major hepatic resections
23. Circulatory changes associated with major hepatic resection
24. Acute portal hypertension associated with liver resection: Analysis of early postoperative death
25. Liver blood flow after major hepatic resection
26. Chemical and biochemical aspects of platelet activationg factor: A novel class of acetylate ether-linked choline phospholipids
27. Platelet-activating factor: A biological active phosphoglyceride
28. Monocyte aggregation and superoxide anion release in response to FMLP and platelet-activating factor (PAF)
29. Biological significance of enhanced mitochondrial membrane potential in regenerating liver
30. Sinusoidal endothelial liver cells in vitro release endothelin: Augmentation by transforming growth factor β and Kuppfer cell-conditioned media
31. Endothelin-1-induced vasoconstriction causes a significant increase in portal pressure of rat liver: Localized constrictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction
32. The roles of platelet-activating factor and endothelin 1 in renal damage after total hepatic ischemia and reperfusion
33. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo
34. Neutrophil elastase inhibitor reduces neutrophil chemoattractant production after ischemia-reperfusion in rat liver
35. Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion
36. Platelet-activating factor is involved in the regulation of pathological leukocyte adhesion after liver transplantation